These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 5420748)
61. Lipids and the pill. Alfin-Slater RB; Aftergood L Lipids; 1971 Oct; 6(10):693-705. PubMed ID: 4947759 [No Abstract] [Full Text] [Related]
62. [Trends in drug-hormone contraception]. Kuemmerle HP Int Z Klin Pharmakol Ther Toxikol; 1968; 1(6):465-6. PubMed ID: 5718773 [No Abstract] [Full Text] [Related]
63. Serum lipids and lipoproteins during treatment with oral contraceptives containing natural and synthetic oestrogens. A controlled double-blind investigation. Bostofte E; Hemmingsen L; Møller KJ; Serup J; Weber T Acta Endocrinol (Copenh); 1978 Apr; 87(4):855-64. PubMed ID: 347855 [TBL] [Abstract][Full Text] [Related]
64. Growth of leiomyomata with estrogen--progestogen therapy. John AH; Martin R J Reprod Med; 1971 Feb; 6(2):56-8. PubMed ID: 5115282 [No Abstract] [Full Text] [Related]
65. The effect of kind of carbohydrate in the diet and use of oral contraceptives on metabolism of young women. II. Serum lipid levels. Behall KM; Moser PB; Kelsay JL; Prather ES Am J Clin Nutr; 1980 Apr; 33(4):825-31. PubMed ID: 7361701 [TBL] [Abstract][Full Text] [Related]
66. [Influence of oral contraceptives on the nasal mucosa]. Ammar-Kohdja A Rev Laryngol Otol Rhinol (Bord); 1971; 92(1):40-2. PubMed ID: 5574270 [No Abstract] [Full Text] [Related]
67. The effect of sequential oral contraceptive pill (Fysioquens) administration on carbohydrate and lipid metabolism. Vähäpassi J; Pyörälä T Ann Chir Gynaecol; 1979; 68(2):75-81. PubMed ID: 507744 [TBL] [Abstract][Full Text] [Related]
69. [On the side effects of treatment with hormone preparations consisting of estrogen-gestagen combinations]. Osler M Ugeskr Laeger; 1967 Mar; 129(9):294-6. PubMed ID: 5599492 [No Abstract] [Full Text] [Related]
70. Effects of clofibrate and of an estrogen-progestin combination on fasting biliary lipids and cholic acid kinetics in man. Pertsemlidis D; Panveliwalla D; Ahrens EH Gastroenterology; 1974 Apr; 66(4):565-73. PubMed ID: 4821079 [TBL] [Abstract][Full Text] [Related]
71. [3 further cases of icterus after taking estroprogestational agents and troleandomycin]. Descotes J; Evreux JC; Foyatier N; Gaumer R; Girard D; Savoye B Nouv Presse Med; 1979 Mar; 8(14):1182-3. PubMed ID: 313558 [No Abstract] [Full Text] [Related]
72. Oral contraceptives and cardiovascular disease (first of two parts). Stadel BV N Engl J Med; 1981 Sep; 305(11):612-8. PubMed ID: 7022208 [No Abstract] [Full Text] [Related]
73. Comparative studies of the ethynyl estrogens used in oral contraceptives. VII. Effects with and without progestational agents on ultracentrifugally fractionated plasma lipoproteins in humans, baboons, and beagles. Goldzieher JW; Chenault CB; de la Peña A; Dozier TS; Kraemer DC Fertil Steril; 1978 Nov; 30(5):522-33. PubMed ID: 214353 [TBL] [Abstract][Full Text] [Related]
74. Oral contraceptive agents and the glucose tolerance problem. Cohn RE Pa Med; 1971 Jan; 74(1):62-4. PubMed ID: 5540284 [No Abstract] [Full Text] [Related]
75. Oral progestational agents as a cause of Candida vaginitis. Walsh H; Hildebrandt RJ; Prystowsky H Am J Obstet Gynecol; 1968 Aug; 101(7):991-3. PubMed ID: 5659957 [No Abstract] [Full Text] [Related]